Cigna ( (CI) ) has released its Q2 earnings. Here is a breakdown of the information Cigna presented to its investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The Cigna Group is a global health company that offers a wide range of health services and insurance products, operating primarily in the healthcare and pharmacy sectors. The company is known for its commitment to innovation and improving health outcomes for individuals and communities worldwide.
In its latest earnings report for the second quarter of 2025, The Cigna Group reported strong financial results, with total revenues increasing by 11% to $67.2 billion. The company also reaffirmed its adjusted earnings per share outlook for the year, highlighting its robust performance across various business segments.
Key financial metrics from the report include a shareholders’ net income of $1.5 billion, or $5.71 per share, and an adjusted income from operations of $1.9 billion, or $7.20 per share. The revenue growth was primarily driven by Evernorth Health Services, which saw significant increases in both pharmacy benefit services and specialty care services. However, the Cigna Healthcare segment experienced a decrease in adjusted revenues due to the impact of a recent divestiture.
Despite some challenges, such as higher medical costs in the Cigna Healthcare segment, the company demonstrated strong operational execution. The SG&A expense ratio improved, reflecting a favorable business mix and revenue growth. Customer relationships also showed positive trends, with total pharmacy customers increasing by 3%.
Looking ahead, The Cigna Group remains optimistic about its financial performance for the remainder of 2025. The company expects to achieve an adjusted income from operations of at least $29.60 per share, driven by continued growth in its core business areas and strategic initiatives aimed at enhancing shareholder value.

